Fed. Circ. Upholds Validity Of Depomed Drug Patents
The Federal Circuit on Thursday affirmed decisions by the Patent Trial and Appeal Board that two Depomed patents for extended-release drug technology are not invalidated by prior art....To view the full article, register now.
Already a subscriber? Click here to view full article